Mesentech is a clinical stage biotechnology company developing novel medicines that selectively distribute to the intended site of action.
MES1022 is a clinical stage program for bone-repair being developed for 3 indications. Our preclinical pipeline includes novel compounds targeting bone-cancers.
Company Details
- Employees
- 16
- Founded
- -
- Address
- Vancouver, British Columbia V6t, Ca
- Phone
- 778-231-2500
- Industry
- Biotechnology
- Website
- mesentech.com
- Keywords
- osteoporosis, osteogenesis imperfecta, brittle bone disease, orphan disease, implants, fracture healing, regenerative medicine, bone-graft, biomaterials, bone, bone-loss, drug conjugate, Duchenne.
- HQ
- Vancouver, British Columbia
Mesentech Questions
Mesentech's helpline number is 778-231-2500
Mesentech's website is mesentech.com
Mesentech's LinkedIn profile is https://ca.linkedin.com/company/mesentech
Mesentech has
16 employees.
View email and phone details for 16
employees at Mesentech.
Mesentech's industry is
Biotechnology
Mesentech's top competitors are
Lucent Bio,
Augurex Life Sciences Corp.,
Reverb Therapeutics,
Seragene Therapeutics,
Kapoose Creek Bio,
Healwell Ai (Tsx: Aidx),
Voxcell Bioinnovation,
Lethub,
Acuitas Therapeutics,
Rise People.
Mesentech's categories are Biotechnology
Mesentech's founding year is 2018
